Search

Author/Creator Finlayson, Jim

1. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial. Issue 10359 (8th October 2022)

Authors:
Mackenzie, Isla S; Hawkey, Christopher J; Ford, Ian; Greenlaw, Nicola; Pigazzani, Filippo; Rogers, Amy; Struthers, Allan D; Begg, Alan G; Wei, Li; Avery, Anthony J; Taggar, Jaspal S; Walker, Andrew; Duce, Suzanne L; Barr, Rebecca J; Dumbleton, Jennifer S; Rooke, Evelien D; Townend, Jonathan N; Ri...
Journal:
Lancet
Issue:
Volume 400:Issue 10359(2022)
Page Start:
1195
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Issue 10349 (30th July 2022)

Authors:
Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ...
Journal:
Lancet
Issue:
Volume 400:Issue 10349(2022)
Page Start:
359
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10387 (6th May 2023)

Authors:
Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ...
Journal:
Lancet
Issue:
Volume 401:Issue 10387(2023)
Page Start:
1499
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Issue 10369 (17th December 2022)

Authors:
Kalra, Paul R; Cleland, John G F; Petrie, Mark C; Thomson, Elizabeth A; Kalra, Philip A; Squire, Iain B; Ahmed, Fozia Z; Al-Mohammad, Abdallah; Cowburn, Peter J; Foley, Paul W X; Graham, Fraser J; Japp, Alan G; Lane, Rebecca E; Lang, Ninian N; Ludman, Andrew J; Macdougall, Iain C; Pellicori, Pier...
Journal:
Lancet
Issue:
Volume 400:Issue 10369(2022)
Page Start:
2199
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗